CRNX R&D Expense Growth
Crinetics Pharmaceuticals Inc · R&D Expense Growth
CRNX R&D Expense Growth
Latest reported38.27%period ending
CRNX FY R&D Growth (YoY) (0.00% → 38.27%)
Latest values, visible window
High-resolution chart · PNG
CRNX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 38.2676% | |
| 42.503% | |
| 29.4122% | |
| 54.5606% | |
| 46.2811% | |
| 38.7703% | |
| 69.5576% | |
| 165.1251% | |
| 81.0392% | |
| 0% |